---
kind: "section"
citation: "42 U.S.C. § 300hh–31"
title: "42"
title_heading: "The Public Health and Welfare"
number: "300hh–31"
heading: "Epidemiology-laboratory capacity grants"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/42/300hh-31"
units:
  - "Chapter 6A — Public Health Service"
  - "Subchapter XXVI — National All-Hazards Preparedness for Public Health Emergencies"
  - "Part C — Strengthening Public Health Surveillance Systems"
---

# §300hh–31. Epidemiology-laboratory capacity grants

- (a) **In general—** Subject to the availability of appropriations, the [Secretary](/usc/42/201.md?p=c), acting through the [Director](/usc/42/11851.md?p=5) of the Centers for Disease Control and Prevention, shall establish an Epidemiology and Laboratory Capacity Grant [Program](/usc/42/274l–1.md?p=4) to award grants to [State](/usc/42/201.md?p=f) health departments as well as local health departments and tribal jurisdictions that meet such criteria as the [Director](/usc/42/11851.md?p=5) determines appropriate. Academic centers that assist [State](/usc/42/201.md?p=f) and eligible local and tribal health departments may also be eligible for funding under this section as the [Director](/usc/42/11851.md?p=5) determines appropriate. Grants shall be awarded under this section to assist public health [agencies](/usc/42/8262.md?p=1) in improving surveillance for, and response to, infectious diseases and other conditions of public health importance by—
  - (1) strengthening epidemiologic capacity to identify and monitor the occurrence of infectious diseases, including mosquito and other vector-borne diseases, and other conditions of public health importance;
  - (2) enhancing laboratory practice as well as systems to report test orders and results electronically;
  - (3) improving information systems including developing and maintaining an information [exchange](/usc/42/300gg–91.md?p=d-21) using national guidelines and complying with capacities and functions determined by an [advisory council](/usc/42/274l–1.md?p=1) established and appointed by the [Director](/usc/42/11851.md?p=5); and
  - (4) developing and implementing prevention and control strategies.
- (b) **Authorization of appropriations—** There are authorized to be appropriated to carry out this section $190,000,000 for each of fiscal years 2019 through 2023, of which—
  - (1) not less than $95,000,000 shall be made available each such fiscal year for activities under paragraphs [(1)](#a-1) and [(4)](#a-4) of subsection (a);
  - (2) not less than $60,000,000 shall be made available each such fiscal year for activities under [subsection (a)(3)](#a-3); and
  - (3) not less than $32,000,000 shall be made available each such fiscal year for activities under [subsection (a)(2)](#a-2).

## Source credit

(July 1, 1944, ch. 373, title XXVIII, § 2821, as added Pub. L. 111–148, title IV, § 4304, Mar. 23, 2010, 124 Stat. 584; amended Pub. L. 116–22, title VI, § 607(b), June 24, 2019, 133 Stat. 960.)

## Notes

### Editorial Notes

### Amendments

2019—Subsec. (a)(1). Pub. L. 116–22, § 607(b)(1), inserted “, including mosquito and other vector-borne diseases,” after “infectious diseases”.

Subsec. (b). Pub. L. 116–22, § 607(b)(2), substituted “2019 through 2023” for “2010 through 2013” in introductory provisions.